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The metabolism of the parasite Trypanosoma brucei has been the focus of numerous stud-
ies since the 1940s. Recently it was shown, using metabolomics coupled with heavy-atom
isotope labelled glucose, that themetabolism of the bloodstream form parasite is more com-
plex than previously thought. The present study also raised a number of questions regarding
the origin of several metabolites, for example succinate, only a proportion of which de-
rives from glucose. In order to answer some of these questions and explore the metabolism
of bloodstream form T. brucei in more depth we followed the fate of five heavy labelled
amino acids – glutamine, proline, methionine, cysteine and arginine – using an LC–MS based
metabolomics approach. We found that some of these amino acids have roles beyond those
previously thought and we have tentatively identified some unexpected metabolites which
need to be confirmed and their function determined.
Introduction
Trypanosoma brucei is the causative agent of human and animal African trypanosomiasis. It is a proto-
zoan parasite, transmitted to its mammalian host via a tsetse fly vector. In both hosts the parasite is extra-
cellular, proliferating in themammalian bloodstream and central nervous system and the tsetse flymidgut
fromwhere it migrates through different body tissues before reaching the salivary gland for transmission.
T. brucei metabolism is adapted to these disparate environments and significant differences distinguish
its metabolism in the different forms of the parasite [1,2].
Within the fly, the main carbon and energy source of the procyclic form trypanosomes is proline, while
the bloodstream formparasite uses glucose fed glycolysis as itsmain energy source [3]. Because of the very
high rate of glycolysis, it had long been accepted that the glucose consumed by the parasite was essentially
excreted as pyruvate and glycerol. However, the availability of high throughput metabolomics technol-
ogy, in conjunction with use of isotope labelled substrates, has permitted extensive tracing of glucose
metabolism in both the procyclic form [3] and bloodstream form [5] organisms. In bloodstream forms it
is clear that glucose enters a plethora of pathways beyond simple glycolysis [5], as is also true for the pro-
cyclic form. Unexpected metabolites such as octulose 8-phosphate were identified and labelling patterns
revealed a significant role for a succinate shunt generating partially oxidised end products of metabolism.
Interestingly, only a proportion of some of these end products, including succinate, is derived from glu-
cose, implying that other sources are used by the cell in their production. It has also been shown in in
vitro culture that bloodstream form organisms consume substantial quantities of threonine [6,7] and that
a supply of either the aromatic amino acids (tryptophan, tyrosine and phenylalanine) or glutamine was
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Figure 1. Glutamine labelled experiments results
The bar charts show the measured proportions of the different number of 13C: grey represents fully unlabelled metabolite, blue 1
carbon 13C, brown 4 carbons 13C and orange 5 carbons 13C. The green dots on the molecules represent the theoretical individual
13C starting with a fully labelled precursor following this pathway.
necessary for growth [6]. These appear to be critical cellular sources of nitrogen, fixed via aminotransferase actions.
Intriguingly, indole pyruvate, the product of tryptophan has possible immunomodulatory roles [8].
Amino acids clearly play key roles in many aspects of trypanosomemetabolism. For example, the unusual metabo-
lite trypanothione (N1,N8-bis(glutathionyl)-spermidine) derives from glutathione (itself consists of the glutamate,
cysteine, glycine tripeptide) and the polyamine spermidine, which derives from ornithine via putrescine through
sequential addition of aminopropyl groups from decarboxylated S-adenosylmethionine, itself a product of methio-
nine and adenosine. In order to learn more about the utilisation of different amino acids across the trypanosome’s
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Figure 2. Trypanothione biosynthesis pathway as seen using 50% U-13C glutamine, cysteine or methionine
The bar charts show the measured proportions of the different number of 13C (colour code is shown at the top of the figure). The
green dots on the molecules represent the theoretical individual 13C coming from fully labelled glutamine, blue carbons come from
fully labelled cysteine and red from fully labelled methionine.
metabolic network we have investigated the distribution of atoms derived from glutamine, proline, methionine, cys-
teine and arginine using heavy labelled precursors and LC–MS, as these five amino acids will address specific gaps in
our current metabolic map as detailed below.
Materials and Methods
Parasite culture and argk generation
T. brucei brucei bloodstream form (s427) was cultured in vitro in Creek’s ‘Minimal’ Media (CMM) [6] with 10%
FBS Gold at 37◦C, 5% CO2. For continuous growth, cell densities were kept between 5 × 104 and 2 × 106 cells/ml
and the cell density was checked every 48 h using an improved Neubauer haemocytometer. For growth curves, the
cells were counted every 24 h and cell counts performed in triplicate.
The three arginine kinase genes, Tb427tmp.160.4560, Tb427tmp.160.4570, Tb427tmp.160.4590 (Tb927.9.6290,
Tb927.9.6250 and Tb927.9.6210 in the 927 reference genome) were knocked out in the bloodstream form s427 strain
to obtain strain Δak. The three isoforms are located in an array in the genome (Supplementary Figure S1A), in-
terspaced by a putative gene with unknown function Tb427tmp.160.4580 (Tb927.9.6270). A strategy was designed
where the region covering all four genes was replaced with antibiotic resistance cassettes (Supplementary Figure S1B).
The 5′ and 3′ flanking regions were amplified from genomic DNA (all primers are detailed in Supplementary Table
S1) and cloned flanking a hygromycin or puromycin resistance cassette in vector pTBT [9]. Parasites were trans-
formed in two rounds with NotI-linearised constructs as described previously [10], to replace both allelic regions
with the hygromycin and puromycin resistance cassettes through homologous recombination. Positive clones were
selected with 2.5 μg/ml hygromycin and 0.2 μg/ml puromycin, and correct integration of the resistance cassettes was
confirmed by PCR (Supplementary Figure S1C). Absence of additional isoforms of TbAK in theΔak strain was val-
idated by PCR, following standard procedures [11] and probed with Easytides 32P-ATP (Perkin Elmer) incorporated
into TbAK using the Stratagene Prime-it kit.
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Figure 3. Putative methylthio-D-ribose in the U-13C methionine experiment (A and B) and in Kim et al. [18] spend medium
experiment (C and D)
Intracellular metabolite extraction from parasites
Trypanosomes were grown to mid-log phase and a sample volume equivalent to 5 × 107 cells was rapidly cooled to
4◦Cby submerging a 50ml Falcon tube containing the parasites in a dry ice/ethanol bath. Samples were kept on ice (or
4◦C) from this step onwards. Samples were centrifuged at 1250g for 10 min, and most supernatant, except 1 ml, was
removed. The pellet was resuspended in the remaining 1 ml of medium. This was transferred to an Eppendorf tube
and briefly centrifuged at 1250g to completely remove the supernatant. The cell pellet was washed in cold 1× PBS and
metabolites extracted by resuspending in 100μl chloroform:methanol:water (ratio1:3:1 v/v/v) with internal standards
and by vigorously shaking for 1 h at 4◦C. Samples were centrifuged at 16,000g for 10min and the supernatant collected
and stored at −80◦C under argon.
13C-labelled tracking
T. b. brucei strain 427was grown inCMM+10%FBSGold (PAA, Piscataway, NJ) at 37◦C, 5%CO2 forU-13C-labelled
tracking. For l-methionine studies, a 1:1mix of unlabelled andU-13C l-methionine (50μMl-methionine and 50μM
U-13C l-methionine) was added to the parasite culturemedium (starting density of 2× 104 cells/ml). For l-glutamine
and l-cysteine studies, a 1:1 mix of unlabelled and U-13C glutamine or cysteine (500 μM unlabelled and 500 μM
U-13C) was added to the parasite culture medium. For l-proline and l-arginine, 100% labelled compound was used
at a concentration of 200 μM as significant levels of unlabelled l-proline and l-arginine are present in the serum.
Cells were incubated at 37◦C, 5% CO2 for 48 h, and metabolites extracted as described above. Samples were prepared
in triplicate (biological replicates) and for every labelled setup a control with the equal concentration of unlabelled
compound was set up, also in triplicate. Fresh medium and spent medium controls (for the l-methionine, l-proline
and l-arginine experiments) were also collected and 5 μl were added to 100 μl extraction solvent (CMW 1:3:1) prior
to analysis.
Labelled compounds were obtained from Cambridge Isotope Laboratory, Inc.: (l-methionine, 13C5, enrichment
99%, cat: CLM-893-H-0.1; l-proline, 13C5, enrichment 99%, cat: CLM-2260-H; l-arginine, 13C6, enrichment 99%,
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cat: CLM-2265-H-0.1; l-cysteine, 13C3, enrichment 99%, cat: CLM-4320-H-PK; l-glutamine, 13C5, enrichment 99%,
cat: CLM-1822-H-PK).
Sample preparation for pH stress
T. b. brucei strain 427 wild type (WT) and arginine kinase knockout (Δak) cells were cultured in CMM with 10%
FBS Gold at 37◦C, 5% CO2 as described above and allow them to reach a density of 2 × 106 cells/ml. After a density
of 2 × 106 cells/ml was achieved, WT and Δak cells were centrifuged at 1250g for 10 min and the cells were then
resuspended in CMM at pH 8.7 (pH stress) and pH 7.4 (controls) and incubated for 120 min.
The cells were then extracted as described in the section ‘Intracellular metabolite extraction from parasites’. Equal
volumes from all the samples were mixed to create a quality control (QC) sample in order to assess instrument per-
formance. All samples were prepared in four biological replicates.
Liquid chromatography–mass spectrometry
The sample platform chosen for this project was liquid chromatography coupled withmass spectrometry. All samples
were separated on a Dionex Ultimate 3000 RSLC liquid chromatography system (Dionex, Camberley, Surrey) with
ZIC-pHILIC 150× 4.6 mm, 5 μm column (Merck Sequant) prior to mass detection on an Q-Exactive Orbitrap mass
spectrometer (Thermo Fisher Scientific, Hemel Hempstead, U.K.). LC–MS analysis was performed in positive and
negative electrospray mode (m/z 70–1400, resolution 50,000), using 10 μl injection volume and a flow rate of 300
μl/min. For HPLC gradient, ZIC-pHILIC solvent A was 20 mM ammonium carbonate in H2O, and solvent B was
100% acetonitrile. A linear gradient of the mobile phases was applied, in which samples were eluted from 80% B to
5% B over 15 min, followed by another linear gradient from 5% B to 80% B over 2 min, and 80% B was held for 7 min
for re-equilibration. With each experiment a set of authentic standards was run prior to the sample set.
Data processing and analysis
Raw LC–MS data files were converted to mzXML using ProteoWizard msconvert [12]. Data were processed using
XCMS [13] for peak picking and mzMatch for peak grouping, filtering and putative identifications [14]. Metabo-
lite identification was performed by matching accurate masses and retention times of authentic standards. Level 1
metabolite identification according to the metabolomics standards initiative [15,16], but when standards were not
available masses and labelling patterns were used, hence these identifications should be considered as putative (Level
2 identification). Isotopic profiles were analysed using mzMatch-ISO [4].
In order to visualise metabolic differences between control and high pH treated cells, orthogonal partial least
squares-discriminant analysis (OPLS-DA) was carried out by SIMCA-P 14.1 (Umetrics AB, Umea, Sweden). Mass
ions (m/z) that were changed significantly between the two groups were selected by variable importance in projec-
tion values (VIP)where the values greater than onewere determined as potential keymarkers. Additionally, univariate
t-test analysis was performed using a web-based analysis tool,Metaboanalyst [17] to cross check significant difference
between control and treated cells.
The mzXML files of all the experiments described in the present study are available in the Metabolights database
at https://www.ebi.ac.uk/metabolights/MTBLS624.
Results and discussion
A recent study by Creek et al. [5] showed that glucose was a source of carbon for many pathways beyond glycolysis.
The present study also raised new questions, as many of these pathways only use glucose for part of their carbon
needs. To extend the measured metabolic map of bloodstream form T. brucei, we followed the fate of five key amino
acids, arginine, cysteine, glutamine, methionine and proline inside the cells, using U-13C-labelled amino acids and
LC–MS.
Glutamine
As previously reported [6,7,18], glutamine is consumed by bloodstream formT. brucei fromCMM in large quantities
where it has been proposed it mainly serves as a key amino group donor. 2-Oxoglutarate and 2-oxoglutaramate as
well as some glutamate are secreted into the medium as bloodstream forms grow [6,18]. Furthermore, significant
quantities of succinate are secreted by bloodstream forms [6,7,18], of which only 52% comes from glucose via the
essential phosphoenolpyruvate carboxykinase [5]. The remaining succinate must be produced from another carbon
source, and glutamine-derived 2-oxoglutarate is a likely candidate. To test this hypothesis, we incubated T. brucei
© 2019 The Author(s). This is an open access article published by Portland Press Limited on behalf of the Biochemical Society and distributed under the Creative Commons Attribution
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Figure 4. Pyruvate (A and B) and alanine (C and D) as seen in the 50% U-13C glutamine experiment
bloodstream form for 48 h in CMM with 50% U-13C glutamine and then analysed the intracellular metabolome
using LC–MS (see Materials and Methods).
The results (see Figure 1) reveal that 45% of intracellular glutamine is 5 carbon labelled (additional unlabelled glu-
tamine from the serum likely having a small dilution effect). Acetylated glutamine is also present (N-acetylglutamine
labelled at 37 +− 8%). Glutamate is 37.5 +− 0.3% fully labelled and 2-oxoglutarate 39.0 +− 0.3%; confirming that the
primary source of glutamate and 2-oxoglutarate inside the cell is medium-derived glutamine. Labelling can also be
seen in glutathione (39.4 +− 0.1%) and trypanothione disulphide (39 +− 1%), as expected (see Figure 2).
Although a canonical glutaminase (EC 3.5.1.2) encoding gene cannot be found in the T. brucei genome [19],
several reactions could be responsible for producing glutamate from glutamine, for example: (i) a GMP synthase
(EC. 6.3.5.2, gene Tb927.7.2100) that converts XMP to GMP uses glutamine as an amino group donor [20], (ii) a
glutamine-dependent carbamoyl-phosphate synthase (EC 6.3.5.5, putative gene Tb927.5.3800, syntenic orthologue
of the identified Leishmania mexicana and Trypanosoma cruzi genes [21] also uses glutamine as an amino group
donor to produce carbamoyl-phosphate from hydrogen carbonate [22] and is also essential [23], (iii) an asparagine
synthase (Tb927.7.1110) can use either ammonia (EC 6.3.1.1) or glutamine to produce asparagine from aspartate
[24].
Many reactions can produce 2-oxoglutarate from glutamate. For example, in T. brucei, glutamate dehydrogenase
[25]. Two isoforms of aspartate aminotransferase (EC 2.6.1.1, mitochondrial isoform gene Tb927.11.5090, cytosolic
isoform gene Tb927.10.3660) are also present in bloodstream forms [27] and alanine aminotransferase (EC 2.6.1.2,
gene Tb927.1.3950) is expressed at high levels [28]. The putatively identified 2-oxoglutaramate is present in the la-
belled form at high levels (43.5 +− 0.1%) and is probably derived from the glutamine aminotransferase (EC 2.6.1.15,
gene Tb927.10.11970) that produces 2-oxoglutaramate and alanine from glutamine and pyruvate [28].
6 © 2019 The Author(s). This is an open access article published by Portland Press Limited on behalf of the Biochemical Society and distributed under the Creative Commons Attribution
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The total succinate pool is present with 14.9 +− 0.1% containing 4 labelled carbons indicating that part of the total
succinate pool is derived from glutamine, most likely via 2-oxoglutarate. Indeed, enzyme activities of 2-oxoglutarate
dehydrogenase (EC 1.2.4.2) and acetyl:succinate CoA-transferase (EC 2.8.3.18, gene Tb927.11.2690) have been mea-
sured in bloodstream forms, albeit at lower levels than in procyclics [29,30]. In addition to succinate, 4 carbon labelled
malate is also present (6.2 +− 0.1% of the total measured malate) presumably due to a reverse flux from succinate [7].
Malate then contributes to the low levels of labelled aspartate (2.6 +− 0.2% of the total) via malate dehydrogenase
(EC 1.1.1.299, cytosolic isoform gene Tb927.11.11250) [29,31,32] and aspartate aminotransferase. The promiscu-
ous action of malate dehydrogenase on 2-oxoglutarate [33] also produces 5 carbon labelled 2-hydroxyglutarate [34]
(34.1+− 0.5% of the total) which is transformed to 2-oxoglutarate by 2-hydroxyglutarate dehydrogenase (EC 1.1.99.2,
putatively annotated gene Tb927.10.9360).
Bloodstream form T. brucei contain large concentrations of pyruvate and alanine in their cytoplasm [18,35], most
of which is derived fromglucose (close to 100% in [5], although labelling experiments show that a small but significant
quantity of the total (0.4+− 0.02% of the pyruvate and 0.3+−0.03% of the alanine) is labelled from glutamine (see Figure
4). Malic enzyme (EC 1.1.1.40, mitochondrial isoform Tb927.11.5450, cytosolic isoform Tb927.11.5440), the activ-
ity of which has been measured in bloodstream forms [29,33,36,37] could produce this pyruvate and subsequently
alanine via alanine aminotransferase and glutamine aminotransferase.
Small amounts of 5 carbon labelled citrate/isocitrate (these two isomers cannot be distinguished on this plat-
form) and cis-aconitate (4.0 +− 0.6% of citrate and less than 1% of cis-aconitate) also derive from the labelled glu-
tamate, as also seen from labelled glucose (approx. 11% of citrate/isocitrate is found labelled from glucose and
5% of cis-aconitate) [5]. Isocitrate dehydrogenase can produce isocitrate from 2-oxoglutarate (EC 1.1.1.42, gene
Tb927.11.900) and the protein is identified in bloodstream forms [33,37,38] despite its activity being below the de-
tection threshold when assayed [30]. Aconitase activity was detectable [30] and the protein detected [39] (EC 4.2.1.3,
gene Tb927.10.14000), thus explaining the labelled cis-aconitate and citrate. The proportion of the labelled deriva-
tives is lowwhen compared with unlabelled due to the parasites accumulating large quantities of citrate frommedium
[38]. It is clear that glutamine can be used to fuel various pathways in bloodstream form T. brucei, with a primary
role in provision of amino groups to the nitrogen pool of the parasites.
Proline
Proline is the primary source of carbon and energy in procyclic form trypanosomes and critical to viability in the
tsetse fly [40]. Enzymes involved in its catabolism are substantially less abundant in the bloodstream form and it
has been assumed that proline has little metabolic use to these cells [41]. Given that the presence of peptidases in
the medium increases the concentration of unlabelled proline over time [18], the cells were incubated in medium
containing 200μMproline 100%U-13C-labelled. After 48 h 49+− 1%of the proline inside cells was labelled (unlabelled
proline coming from the serum causes the dilution) while very small quantities (less than 1%) of succinate, malate,
2-oxoglutarate and glutamate were labelled (4 carbons for succinate and malate, 5 for glutamate and 2-oxoglutarate)
(see Supplementary File S4) confirming that these cells barely utilise l-proline through catabolic pathways although
they maintain low level activity of the enzymes necessary to do so.
Methionine
Methionine has several roles of fundamental importance in trypanosomes. For example, it is the primary source of
methyl groups in a multitude of reactions when converted to S-adenosylmethionine (AdoMet) and also of amino-
propyl groups in growing polyamine chains after production of the decarboxylated form. Creek et al. previously
revealed that S-adenosyl-l-methionine is 5 carbon labelled when using U-13C glucose due to labelling of the ribose
moiety of the adenosyl group (76% labelled in [5]. Decarboxylated Adomet is used exclusively for the conversion
of putrescine to spermidine which creates S-methyl-5′-thioadenosine (MTA) once the aminopropyl group has been
transferred to the growing polyamine chain. In many cell types, MTA is recycled to methionine and this was pre-
sumed to occur also for bloodstream form T. brucei [42]. However, Creek et al. showed this is not the case. Labelling
with 50%U-13C l-methionine and identifying its metabolic products both within the parasites and their medium has
given more insight into the fate of MTA, whose accumulation is generally toxic [43,44].
MTA is not converted to l-methionine (see Figure 2) using the classical methionine cycle since this pathway would
create 1 carbon labelled l-methionine from U-13C l-methionine and no excess 1 carbon labelled product is detected
when compared with the unlabelled control. 35 +− 6% of intracellular methionine is labelled with 5 carbons for 48 h
and 28.2 +− 0.1% of S-adenosyl-l-methionine is also 5 carbon labelled. A peak corresponding to the mass of MTA
was labelled with a single carbon (36 +− 2% 1 carbon 13C-labelled). This peak is only detected within cells and not in
© 2019 The Author(s). This is an open access article published by Portland Press Limited on behalf of the Biochemical Society and distributed under the Creative Commons Attribution
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Figure 5. S-Adenosylhomocysteine recycling pathway
The bar charts show the measured proportions of the different number of 13C (colour code is shown at the top of the figure). The
blue dots on the molecules represent the theoretical individual 13C coming from cysteine and red from methionine.
the spent medium. By contrast, a low intensity peak with a significant proportion of 1 carbon label corresponding to
the mass of methylthioribose was identified in spent medium (see Figure 3A,B). Since this peak was of low intensity
we investigated its appearance in spent medium in a time course experiment [18]. This metabolite accumulates in
the medium proportionally to the cell density (see Figure 3C,D). This indicates that bloodstream form T. brucei
metabolise methionine via AdoMet to MTA which is converted to methylthioribose 1-phosphate (EC 2.4.2.28, gene
Tb927.7.7040) [45], then dephosphorylated to methylthioribose which is secreted from the cell. It appears likely,
therefore, that T. brucei has evolved a mechanism to detoxify MTA generated during polyamine biosynthesis by
converting to MTR which is subsequently secreted from the cell, as is also the case in E. coli [46].
A metabolite with mass consistent with methionine’s ketoacid derivative, 2-oxo-4-methylthiobutanoic acid, was
also identified. Thismetabolite is presentwith 33+− 1%5 carbon labelled both intracellularly and in the spentmedium,
indicating it arises from the transamination ofmethionine and notMTA recycling (in which case it would be 1 carbon
13C-labelled). This transamination is probably catalysed by aspartate aminotransferase [26].
During spermidine synthesis, three carbons in the aminopropyl group released from decarboxylated AdoMet are
labelled and since spermidine is then incorporated into trypanothione we identify 3 carbon labelled trypanothione
(see Figure 2).
S-Adenosyl-l-methionine is also a major methyl group donor. Methylation reactions convert
S-adenosyl-l-methionine into S-adenosyl-l-homocysteine, which we detect with 24 +− 4% 4 carbon labelled
(see Figure 5). Several metabolites can also be detected as methylated derivatives in this experiment (Table 1 gives a
list of the labelled metabolites detected, the number of labelled carbons and their potential functions).
The product of these methylation reactions, S-adenosyl-l-homocysteine is another toxic thiol which needs to be
removed from the system [47]. The classical pathway of detoxification involves a salvage pathway that ultimately
8 © 2019 The Author(s). This is an open access article published by Portland Press Limited on behalf of the Biochemical Society and distributed under the Creative Commons Attribution
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Table 1 Methylated metabolites detected in the U-13C methionine experiment
Metabolite
Source of
identiﬁcation Carbons 13C-labelled Putative function
Putative gene
involved Reference
Nγ-Monomethyl-L-arginine Mass and labelling 1 Protein/histone methylation Tb927.1.4690 (type I)
Tb927.5.3960 (type I)
Tb927.10.640 (type II)
Tb927.7.5490 (type III)
Tb927.10.3560
[48,50] – ﬁve putative
arginine protein
methyltransferases: type I:
[51,52], type II: [53], type III:
[54] (histone: [55,56])
Nω,
Nω′-Dimethyl-L-arginine
Mass and labelling 1 and 2 Protein/histone methylation Tb927.1.4690 (type I)
Tb927.5.3960 (type I)
Tb927.10.640 (type II)
Tb927.10.3560
See
Nγ-monomethyl-L-arginine
N6-Methyl-L-lysine Mass and labelling 1 Protein/histone methylation Tb927.8.1920,
Tb927.1.570
[59–62]
N6,N6,N6-Trimethyl-L-lysine
Mass and labelling 1, 2 and 3 Protein/histone methylation Tb927.8.1920,
Tb927.1.570
See N6-methyl-L-lysine
Methylguanine Mass and labelling 1 RNA cap Tb927.11.4890,
Tb927.10.7940
[59,60]
Nα-Methylhistidine Mass, retention time
(match standard) and
labelling
1 Histidine methylation seen
in histones and other
proteins in Leishmania
[61] (Leishmania)
produces l-cysteine (see Figure 5). Labelled carbons from the methionine precursor are first passed on to homo-
cysteine (undetected) via adenosylhomocysteinase (EC 3.3.1.1, putative gene Tb927.11.9590 [48]), then cystathion-
ine via cystathionine β-synthase (EC 4.2.1.22, putative genes Tb11.02.5400b and Tb11.02.5400 – orthologue of the
identified T. cruzi gene [49]) and finally 2-aminobut-2-enoate via cystathionine γ-lyase (EC 4.4.1.1, putative genes
Tb927.9.12320 and Tb11.v5.0869, orthologues of the identified Leishmania major gene [50] and oxobutanoate). Of
these four metabolites, we detect cystathionine which is indeed 26 +− 1% 4 carbon labelled. This supports the pres-
ence of this salvage pathway as previously indicated by Bacchi et al. using 35S labelledmethionine [51]. However, since
bloodstream form T. brucei consume large quantities of cysteine from their medium [6,52] the salvage pathway is
probably more important in preventing accumulation of toxic S-adenosyl-l-homocysteine and l-homocysteine than
in providing cysteine which needs to be present in the medium for the parasite to be able to grow [52].
Homocysteine can also be reconverted to methionine by 5-methyltetrahydropteroyltriglutamate-homocysteine
S-methyltransferase (EC 2.1.1.14, putative gene Tb927.8.2610) or homocysteine S-methyltransferase (EC 2.1.1.10,
putative gene Tb927.1.1270) [53]. The first reaction would produce four carbons 13C-labelled methionine. How-
ever, whilst a metabolite of this mass is detected, it is also found at the same level in fresh medium containing
U-13C methionine, indicating that it is a contaminant of the label stock and not a product of cellular metabolism.
The second reaction, homocysteine S-methyltransferase [53], would produce U-13C methionine if the co-substrate
S-methyl-l-methionine is also derived from S-adenosyl-l-methionine. However, this pathway would also produce
additional S-adenosyl-l-homocysteine and therefore would not reduce the concentration of this metabolite.
This data indicate that methionine is a key donor of methyl groups following conversion to AdoMet and amino-
propyl groups in polyamine biosynthesis. In each case, potentially toxic by-products are produced, and it appears that
the parasite has evolved a mechanism to detoxify MTA, by conversion in two steps to MTR which is secreted, and
S-adenosyl-l-homocysteine through conversion to cysteine.
Cysteine
26 +− 1% of cystathionine is labelled when U-13C methionine is added to culture medium. As 35 +− 6% of to-
tal intracellular methionine is labelled after 48 h, approx. 74% of cystathionine would appear to come from the
S-adenosyl-l-homocysteine recycling pathway. This indicates that one or more other pathways must account for the
remaining 26%. The most likely additional source of cystathionine is cysteine, which is consumed in large quantities
by bloodstream form T. brucei [6]. Cells were grown for 48 h in CMM containing 50:50 U-13C cysteine: unlabelled
cysteine to follow the fate of cysteine inside the cells.
Labelled cysteine is seen within cells, but the peaks are of too low intensity to allow quantification of relative pro-
portions of labelled and unlabelled versions. Around 20% of cystathionine is labelled at three carbons, indicating
it is derived either from the reverse reaction of cystathionine γ-lyase (Figure 5, reaction 5) or from cystathionine
γ-synthase (Figure 5, reaction 6) [54]. No orthologues of known variants of the latter enzyme are found in the genome
© 2019 The Author(s). This is an open access article published by Portland Press Limited on behalf of the Biochemical Society and distributed under the Creative Commons Attribution
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Figure 6. Coenzyme A biosynthesis pathway
The bar charts show the measured proportions of the different number of 13C (colour code is shown at the top of the figure). The
blue dots on the molecules represent the theoretical individual 13C coming from cysteine.
although the presence of a non-canonical enzyme cannot be excluded. Cysteine-derived carbons could be trans-
ferred to 2-aminoprop-2-enoate by a cystathionine β-lyase (EC 4.4.1.8, protein sequence very similar to cystathio-
nine γ-lyase) [54]. 2-aminoprop-2-enoate would in turn be converted to pyruvate. However, 2-aminoprop-2-enoate
cannot be detected and we cannot see any trace of labelled pyruvate derived from cysteine in this dataset making its
presence unlikely. Only growing cells in the presence of 34S labelled cysteine would allow us to prove or disprove this
hypothesis.
Cysteine is also essential to produce glutathione, trypanothione and coenzyme A (CoA). As expected, glutathione
is present with 39+− 4% 3 carbon 13C-labelled and trypanothione with 38 +− 5% 3 carbon 13C-labelled and 16 +− 2% 6
carbon 13C-labelled (see Figure 2). CoA is most likely produced from pantothenate taken up from the medium (see
Figure 6), even though its consumption rate could not bemeasured due to the small amount likely required by the cells
10 © 2019 The Author(s). This is an open access article published by Portland Press Limited on behalf of the Biochemical Society and distributed under the Creative Commons Attribution
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[18]. Indeed, we can detect coenzyme A and acetyl-CoA with 2 carbon labelled as the biosynthesis pathway predicts.
We also detect a 2 carbon labelled metabolite the mass of which is consistent with pantetheine, a likely fragment
of phosphopantetheine. The first four reactions of CoA synthesis are catalysed by enzymes that are all putatively
annotated in the T. brucei genome but have never been tested (see Figure 6). The fifth reaction, dephospho-CoA
kinase (EC 2.7.1.24, putative gene Tb927.6.710) has been localised to glycosomes [45]. Coenzyme A can then be
converted to acetyl-CoA either via the pyruvate dehydrogenase complex (EC 1.2.1.-) or via the acetyl-CoA synthetase
(EC 6.2.1.1, Tb927.8.2520 [55]) as shown by Mazet et al. [7].
Arginine
Arginine plays several important roles in cellular physiology in many systems. It is, for example, a precursor to
polyamine synthesis inmost systems, producing ornithine via arginase. Furthermore, it generates citrulline and nitric
oxide via the nitric oxide synthase (NOS). A gene encoding an enzyme of the arginase family was found in T. brucei
[56] but the protein lacked arginase activity [57]. Instead it seems that ornithine is accumulated from outside the
cells [58]. Here we investigated the fate of arginine in trypanosomes by growing them in presence of 200 μMU-13C
arginine in CMM.
By the time a steady state was reached, 40 +− 1% of intracellular arginine is fully labelled (a dilution effect is most
likely caused by the peptidases secreted in the medium [18] freeing additional unlabelled arginine from serum pro-
teins). 11.2 +− 0.5% of intracellular ornithine was labelled with 5 13C carbons, consistent with it being produced by
arginase, previously reported asmissing from trypanosomes [57]. However, the same proportion of labelled ornithine
can be seen in the spent medium (but not in the freshmedium), raising the possibility that some arginine is converted
to ornithine in the medium, possibly by arginase in the serum. To test this hypothesis, we added 200 μM of U-13C
arginine to the medium with or without FBS and without adding cells. After 48 h we can see an increase in the la-
belled ornithine produced only with added FBS. This reveals that ornithine is indeed produced from arginine when
no cells are present (see Figure 7) hence the labelled ornithine observed inside trypanosomes appears to be created
by arginase present in serum and then secondarily accumulated by trypanosomes.
The methionine labelling experiment revealed mono and dimethylarginine present with 22 +− 2% and 26 +− 1%
of their total being labelled with 6 carbons. A small proportion of fully labelled citrulline (2.8 +− 0.7%, the fragmen-
tation of this peak was checked and is consistent with citrulline) is also detected in cells but very little in the spent
medium. Since T. brucei does not have NOS activity [59] it is likely that the citrulline derives from dimethylarginine
via dimethylarginase activity although the canonical enzyme is not found in the genome (dimethylated arginines are
found on histones for example).
A metabolite with a mass corresponding to 5-guanidino-2-oxo-pentanoate is also detected (37 +− 1% of its total
quantity labelled). This metabolite would be produced by an aminotransferase reaction using arginine as the nitrogen
donor.
Finally, a metabolite with a mass consistent with l-arginine phosphate is also detected (37 +− 1% being 6 carbon
labelled) which is consistent with the presence of arginine kinase (AK) in these cells (EC 2.7.3.3, gene Tb927.9.6290,
Tb927.9.6250 and Tb927.9.6210) [60], localised to the glycosome, cytosol and flagellum, respectively [60]. In order
to confirm that the arginine phosphate detected was indeed derived fromAK, we knocked out all three highly similar
isoforms of the gene in the BSF of T. brucei (see Supplementary Figure S1). The Δak strain was viable and had a
similar growth rate to the wild type (Figure 8). In addition, untargeted metabolite profiling of the Δak line showed
that arginine phosphate was no longer present, confirming that l-arginine is the sole source of arginine phosphate
in these cells. Interestingly the level of l-arginine was also reduced by 1.7-fold, but no significant global metabolic
changes were observed betweenΔak and wild type cells.
Although no significant metabolic changes were caused by the absence of AK genes, arginine phosphate is be-
lieved to play a critical role as an energy reserve by transferring the high-energy phosphate of arginine-phosphate
back to ADP to form ATP when it is required quickly, for example under severe stress conditions such as starvation,
nutritional and pH stress in trypanosomes [61,62].
The role of AK in trypanosome survival at high pH was also investigated. The survival rate of Δak and WT cells
grown at pH 7.4 (normal growth condition) and 8.7 (high pH condition) was investigated by counting the number
of cells surviving after 72 h of cell culture at each pH condition. The Δak cells showed a 52% decrease in survival
capability at pH 8.7 compared with the cells grown at pH 7.4 (Δak at pH 7.4, (5.78 +− 0.25) × 106 cells/ml; AK KO
at pH 8.7, (3.37 +− 0.12) × 106 cells/ml) whereas the WT cells showed only a 22% decrease in cell density growing
at pH 8.7 (WT cells at pH 7.4, (6.27 +− 0.1) × 106 cells/ml; WT cells at pH 8.7, (5.54 +− 0.47) × 106 cells/ml) (Table
2). This indicates that arginine kinase improves the ability of WT cells to resist high pH stress conditions. In order
© 2019 The Author(s). This is an open access article published by Portland Press Limited on behalf of the Biochemical Society and distributed under the Creative Commons Attribution
License 4.0 (CC BY).
11
Bioscience Reports (2019) 39 BSR20181601
https://doi.org/10.1042/BSR20181601
Figure 7. Peak of ornithine as seen in the medium (CMM) when arginine is fully labelled, with or without FBS but no cells
(Intensity of the peak shown as a function of retention time).
Table 2 Cell counts after 2 h of growth in medium pH 7.4 or 8.7
Cell type pH 7.4 pH 8.7 Decrease (%)
427 WT/ml (×106) 6.27 +− 0.1 5.54 +− 0.47 22
Δak ml−1 (×106) 5.79 +− 0.25 3.37 +− 0.12 52
to further investigate the effects of high pH growth conditions at the molecular level, extracts from theΔak andWT
cells grown under pH 7.4 and 8.7 were analysed by LC–MS. OPLS-DA was then performed to determine specific
metabolites affected by the different growth conditions. As can be seen in Figure 9A, a clear separation was observed
between the normal growth and high pH growth conditions (Δak grown at pH 7.4 (A74) vs pH 8.7 (A87); WT
grown at pH 7.4 (W74) vs pH 8.7 (W87)). Next, to identify which metabolites contributed to the separation, 2-way
orthogonal comparisonsweremade between each cell linewith the twodifferent growth conditions (Figure 9B,C). Key
metabolites contributing to the separation were selected by VIP values higher than one from all 2-way comparisons.
Additionally, the selected metabolites were cross-checked by univariate t-test analysis (with the false discovery rateQ
≤ 0.05). Three metabolites are changed significantly more inΔak cells than inWT, all increased in pH 8.7 compared
12 © 2019 The Author(s). This is an open access article published by Portland Press Limited on behalf of the Biochemical Society and distributed under the Creative Commons Attribution
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Figure 8. Growth of wild type and Δak cells
Figure 9. OPLS-DA scores plot of the metabolomics pH experiment
(A) OPLS-DA including all four groups: WT and ak cells at pH 7.4 and 8.7. (B) OPLS-DA including only ak cells at both pH. (C)
OPLS-DA including only WT cells at both pH.
© 2019 The Author(s). This is an open access article published by Portland Press Limited on behalf of the Biochemical Society and distributed under the Creative Commons Attribution
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Table 3 New metabolites
Formula Carbon labelled Putative source
C8H16N2O4 5 from arginine, 3 from glucose L-Ornithine + pyruvate?
C9H18N4O4 6 from arginine, 3 from glucose L-Arginine + pyruvate?
C8H11NO6S 5 from glutamine, 3 from cysteine Oxoglutarate + cysteine? Product of an aminotransferase
reaction using glutamylcysteine as a substrate?
C10H14N2O7S 5 from glutamine, 3 from cysteine C8H11NO6S + glycine? Product of an aminotransferase
reaction using glutathion as a substrate?
C6H11NO4S 3 from cysteine, 3 from glucose Cysteine + pyruvate?
C6H9NO4S 3 from cysteine, 3 from glucose C6H11NO4S–H2?
C8H17NO6S 3 from cysteine, 5 from glucose Cysteine + pentose?
The formula are assigned based on a measured m/z within 3 ppm of the calculated m/z. No putative identiﬁcation could be made that would match
mass and labelling patterns.
with pH 7.4, and 15 are changed significantly more inWT cells than inΔak, all decreased (see Supplementary Tables
S2 and S3). The role of these metabolites in the response to high pH and their interactions with AK remains to be
investigated.
Unexpected metabolites
Using isotope labelled substrates allows detection of unexpected and novel metabolites too. For example, tracing
U-13C glucose showed the presence of high carbon sugar phosphates such as octulose 8-phosphate and nonulose
9-phosphate as well as a number of pyruvate-derived conjugates in T. brucei [5]. Using U-13C amino acids in the
experiments reported here we are able to add information on the provenance of some of the metabolites identified in
the glucose labelling experiments aswell as detect several newunknownmetabolites (see Table 3). Creek et al. detected
metabolites with masses corresponding to carboxyethyl-l-arginine and carboxyethyl-l-ornithine with 3 carbons 13C
labels derived fromglucose. Labelled arginine confirmed the presence of these twometabolites with the 6 non-glucose
derived carbons of ‘carboxyethyl-l-arginine’ (or d-octopine) coming from arginine and the 5 non-glucose carbons of
‘carboxyethyl-l-ornithine’ coming from arginine via ornithine.
The metabolite with a formula C6H9NO4S was hypothesised to be a pyruvate-cysteine adduct [5] and the cysteine
labelling experiment confirms that the 3 non-glucose derived carbons are from cysteine. A related metabolite of
formula C6H11NO4S which has a different retention time and the same carbon labelling pattern was also found.
A third metabolite containing labelled carbon derived from both glucose and cysteine of formula C8H17NO6S has
a labelling pattern suggestive of its being formed from cysteine and a pentose, most likely ribose. Roles for these
metabolites have not been assigned, and they have not been described in other systems.
Finally, we can also see two metabolites formed from 5 carbons coming from glutamine and 3 carbons from cys-
teine. One has amass thatmatches the formula C8H11NO6S and could be produced from 2-oxoglutarate and cysteine,
possibly the same way glutamylcysteine is produced (see Figure 2). The other has a mass that matches the formula
C10H14N2O7S which could be C8H11NO6S used by glutathione synthetase instead of glutamylcysteine.
All these unexpected metabolites are absent from the fresh medium samples. They could be produced either by
non-enzymatic reactions caused by the accumulation of particular metabolites within cells, or by enzymes using
non-conventional substrates, as is the case for hydroxyglutarate (see section Glutamine). In culture, pyruvate ac-
cumulates to high concentrations inside and outside of the cells [18,35] which could explain the pyruvate derived
metabolites. However, for the glutamine and cysteine derived metabolites accidental enzymatic reactions seem more
likely.
Conclusion
Here we showed how T. brucei bloodstream form cells metabolise five amino acids: glutamine, cysteine, proline, me-
thionine and arginine. In addition to confirming the operation of a range of pathways, both catabolic and anabolic, we
detected possible new metabolites, roles for which will need to be further investigated. Our results also indicate that,
as shown in previous proteomics datasets [63], pathways are likely present in the mitochondrion that were previously
ignored or downplayed, particularly for glutamine consumption. However, only a very low amount of proline is used
by the parasite, indicating that the enzymes are present but only minimally active, perhaps allowing the cells to be
more resistant to changes in their environment.
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